Selective peroxynitrite-mediated protein nitration catalyzed by glyoxalase domain containing protein 4
Abstract
Tyrosine nitration alters the structure, function, and cellular localization of proteins and is implicated in the pathology of multiple diseases [G. Ferrer-Sueta et al. , Chem. Rev. 118 , 1338–1408 (2018), H. Ischiropoulos, Arch. Biochem. Biophys. 356 , 1–11 (1998), I. Griswold-Prenner et al. , J. Biol. Chem. 299 , 105038–10554 (2023)]. Although protein nitration is assumed to proceed via nonspecific chemical mechanisms, it is highly selective, suggesting the possibility of enzymatic catalysis. Here, we showed that glyoxalase domain-containing protein 4 (GLOD4), a previously uncharacterized protein, is an enzyme that catalyzes selective protein nitration. A primary in vivo target for GLOD4-mediated nitration is alpha-synuclein (α-syn), which is central to the pathogenesis of Parkinson’s disease (PD) and related disorders. We document tyrosine nitration of α-syn by GLOD4 in vitro, in cells, and in a murine model of synuclein pathology. The data identified a function of GLOD4 and other structurally related proteins that catalyze the peroxynitrite-mediated selective protein tyrosine nitration. This enzymatic catalysis of nitration may unearth pathophysiological mechanisms and potential interventions in diseases such as PD, cancer, and autoimmunity.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (22)
Sarah Wright
Vu C. Dang
Nitrase Therapeutics
Sami Hussain
Nitrase Therapeutics
Prasanna Kandel
Nitrase Therapeutics
Robert P. Brendza
Nitrase Therapeutics
Sahar Mazhar
Nitrase Therapeutics
Marie Whitmore
Nitrase Therapeutics
Selim Boudoukha
Nitrase Therapeutics
Jaskamaljot Kaur Banwait
Department of Chemistry, The University of Alabama at Birmingham
Robert Van Der Linden
Nitrase Therapeutics
Edward Vertudes
Nitrase Therapeutics
Kate Markham
Nitrase Therapeutics
Marta Trzeciak
Grace Pohan
Nitrase Therapeutics
Andy Jennings
Nitrase Therapeutics
Sheerin Shahidi-Latham
Nitrase Therapeutics
Frank Kayser
Nitrase Therapeutics
Mike Beckstead
Oklahoma Medical Research Foundation
Aaron L. Lucius
Department of Chemistry, The University of Alabama at Birmingham
Arun Kashyap
Nitrase Therapeutics
Harry Ischiropoulos
Children’s Hospital of Philadelphia Research Institute and University of Pennsylvania
Irene Griswold-Prenner
Nitrase Therapeutics